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Abstract
Litomosoides sigmodontis is a cause of filarial infection in rodents. Once infective larvae overcome the skin barrier, they enter
the lymphatic system and then settle in the pleural cavity, causing soft tissue infection. The outcome of infection depends
on the parasite’s modulatory ability and also on the immune response of the infected host, which is influenced by its
genetic background. The goal of this study was to determine whether host factors such as the chemokine axis CXCL12/
CXCR4, which notably participates in the control of immune surveillance, can influence the outcome of the infection. We
therefore set up comparative analyses of subcutaneous infection by L. sigmodontis in two inbred mouse strains with
different outcomes: one susceptible strain (BALB/c) and one resistant strain (C57BL/6). We showed that rapid parasite
clearance was associated with a L. sigmodontis-specific CXCL12-dependent cell response in C57BL/6 mice. CXCL12 was
produced mainly by pleural mesothelial cells during infection. Conversely, the delayed parasite clearance in BALB/c mice
was neither associated with an increase in CXCL12 levels nor with cell influx into the pleural cavity. Remarkably, interfering
with the CXCL12/CXCR4 axis in both strains of mice delayed filarial development, as evidenced by the postponement of the
fourth molting process. Furthermore, the in vitro growth of stage 4 filariae was favored by the addition of low amounts of
CXCL12. The CXCL12/CXCR4 axis thus appears to have a dual effect on the L. sigmodontis life cycle: by acting as a host-cell
restriction factor for infection, and as a growth factor for worms.
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Introduction
Filarioids are parasitic Nematodes transmitted by blood-feeding
arthropods that deliver infective larvae (L3) into the skin of
vertebrate hosts [1]. Some nematode species can host Wolbachia
bacterial endosymbionts [2,3]. A common feature of many filarial
species is their ability to colonize lymphatic vessels: either they
become resident and mature into adults (lymphatic filarioids e.g.
Brugia spp. and Wuchereria), or they use them to reach their
privileged niche (such as coelomic cavities) where they complete
their development [4]. Although the clinical manifestations can be
severe, most of the individuals infected with lymphatic filariasis or
onchocerciasis have asymptomatic infections, associated with
immune regulatory responses that allow long-term survival of
the worms [5–9] .
Litomosoides sigmodontis is a well-established murine model of
filarial infections that mirrors, amongst other things, protective
immune mechanisms [6]. Differences in parasite development
patterns in resistant (i.e. C57BL/6) and susceptible mice (i.e.
BALB/c) is likely to be inherited dominantly by one gene or
closely linked genes as suggested by Choi et al, 2003 [10]. These
differences begin early and become progressively more apparent
[11]. From day 4 post-inoculation of larvae, surviving L3 begin to
appear in the pleural cavity of infected mice. Larvae fully complete
their development in BALB/c mice, from infective L3 larvae into
L4 larvae, and then into mature, sexually reproducing adult filarial
worms. Reduction of filarial load occurs in the pleural cavity, and
is much earlier in C57BL/6 mice than in BALB/c mice. Infection
is almost resolved in C57BL/6 mice by the time patency starts in
BALB/c mice [9]. Another feature of filarial infection in C57BL/6
mice is the higher infiltration of cells in the pleural cavity around
the time of the last molt [12]. Cell recruitment is likely to be due to
inflammatory stimuli and secretion of chemoattractants such as
chemokines.
Chemokines are small proteins that regulate the trafficking of
immune cells through interactions with a subset of 7-transmem-
brane G-protein-coupled receptors [13]. Among them, the
CXCL12/SDF-1 chemokine and its receptor CXCR4 are critical
players [14–16]. CXCL12 is a very potent chemoattractant of
neutrophils, monocytes, T-lymphocytes and eosinophils [17–21],
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influenced by interference in the engagement of CXCL12 with
CXCR4 [22,23].
Beyond its role in leukocyte homeostasis, CXCL12 is a
pleiotropic chemokine that participates in the regulation of tissue
homeostasis (e.g. cell survival/proliferation), the importance of
which is revealed by its essential role in mouse embryonic
development [24–27]. CXCL12 is produced in various tissues,
which include the bone marrow, the skin and cardiac tissues and
the endothelium, peritoneal and pleural mesothelium [28–30].
The CXCL12/CXCR4 axis is known to be involved in viral
infections, autoimmunity, inflammation, immunodeficiency disor-
ders and cancer. An up-regulation of CXCR4 and CXCL12 was
reported in inflammatory diseases, such as rheumatoid arthritis,
multiple sclerosis, nephritis and asthma [31–33]. Recent studies
suggest that disruption of the CXCL12/CXCR4 axis with
pharmacological compounds might prove to be an effective
treatment strategy for such diseases [32,34].
In this study, we hypothesized that the CXCL12/CXCR4 axis
might be involved in the control of filarial infection. We aimed to
define its role using the L. sigmodontis infection model of BALB/c
and C57BL/6 mice, blocking either CXCL12 with the chelator
chalcone C04, or the CXCR4 receptor with the antagonist
bicyclam AMD3100.
Results
Murine strains differ by their pleural environments and
filarial outcomes
Larvae were injected subcutaneously in mice and recovered in
the pleural cavity 10 days (around molt 3), 30 days (around molt
4), and 60 days (onset of blood microfilariae) post inoculation (p.i.).
A later time point (80 days p.i.) was analyzed in BALB/c mice due
to the slower clearance of worms in this strain. As described
previously [12], the number of recovered worms in BALB/c mice
did not vary over the first two months of infection, dropping only
between days 60 to 80 (Figure 1A). In contrast, the number of
recovered worms in C57BL/6 mice decreased more rapidly and is
over before 60 days p.i. (Figure 1A), showing the characteristic
faster destruction of worms in this strain of mice.
The total number of cells recovered in the pleural cavity before
infection was minimal and identical for each strain (Figure 1B).
This number of cells did not vary greatly between 0 h (naive) and
10 days p.i. within strains, or between strains (Figure 1B). As
expected [12], cells were recruited in large numbers 30 days p.i. in
the pleural space, in both strains of mice, though there was a
significant strain effect (Figure 1B). Indeed, at that time point,
recruitment was higher in C57BL/6 than in BALB/c mice
(Figure 1B, 29.3614 vs 15.766.4610
6 cells/mouse). At 30 days
post-inoculation, the number of pleural exudate cells correlates
negatively with the number of filariae recovered in the pleural
cavity (Figure 1D, r=20.576, p,0.01). The total number of cells
recovered from the pleural cavity at 60 days p.i. decreased in both
strains of mice (Figure 1B).
In a previous study, we characterized the infiltrated cells at 10
and 30 days p.i. and found that the kinetics of T and B cell
recruitment are different between the two strains: slow then fast in
C57BL/6 mice vs fast then slow in BALB/c mice [12]. However,
at 30 days p.i., no difference in the proportion of each cell type was
observed between the two strains of mice [12]. The higher peak of
cell influx in the pleural cavity of C57BL/6 mice was associated
with a higher secretion of inflammatory chemokines CCL2, CCL3
and CCL11 (Figure S1 and [12]) in the pleural fluid.
The chemokine CXCL12 attracts a large number of immune
cells and has been shown to be involved in the recruitment of
leukocytes in lung and peritoneal inflammation [35]. CXCL12 is
highly increased in the pleural fluid of C57BL/6 mice 30 days p.i.,
while the level remains unchanged in BALB/c mice, even at day
80 p.i. when the filarial load has fallen (Figure 1C). At 30 days
post-inoculation, the level of CXCL12 in the pleural cavity
correlates with the number of pleural exudate cells (Figure 1E,
r=0.674, p,0.01).
Disruption of the CXCL12/CXCR4 pathway favors worm
survival in C57BL/6 mice
We thus investigated whether the secretion of CXCL12 in the
pleural cavity of C57BL/6 mice might have a hand in the fate of L.
sigmodontis infection by assessing the consequences of a blockade of
the CXCL12/CXCR4 axis in both BALB/c and C57BL/6 mice.
This was done using inhibitors that interact either with the
chemokine (i.e. chalcone C04 [36]) or the receptor (i.e. AMD3100).
We found that intraperitoneal treatments with either chalcone
C04 (at 10 and 20 days p.i., with a2.5 mg/mouse dose) or
AMD3100 (at 10 and 20 days p.i., with a 100 mg/mouse dose)
both significantly increased worm load in C57BL/6 mice. Upon
chalcone C04 administration, the worm load in C57BL/6 mice
reached the one observed in BALB/c mice (Figure 2A). The
AMD3100 treatment appeared to be less potent than the chalcone
C04 one. However, this is likely the consequence of the different
half-lives of the products and their bioavailability, together with
intrinsic differences in their mechanisms of interference on filarial
load. Neither of the treatments modified the filarial load in BALB/
c mice. These results support the hypothesis that CXCL12 has a
role in the resistant phenotype of the C57BL/6 mice.
The treatments with chalcone C04 and AMD3100 reduced the
total number of pleural exudate cell (PleCs) collected in the pleural
lavage fluid of the C57BL/6 mice (Figure 2B). However, PleC
composition was not modified by the treatments (Figure 2C,
Figure S2).
Pleural mesothelial cells are CXCL12 providers in C57BL/6
mice
While CXCL12 levels are highly increased in the pleural fluid of
C57BL/6 mice 30 days p.i (Figure 1C), neither the release of
CXCL12 by infiltrated pleural cells (Figure 3A, Figure S3) nor
blood levels (Figure 3B) can explain such concentrations. It is
known that one main source of CXCL12 are mesothelial cells
[28]. Normal mesothelial cells are present as a single layer applied
to a thin band of fibrous tissue and are characterized by
cytokeratin 7 expression (Figure 3C). Although expression of
CXCL12 was observed in visceral pleural mesothelium from both
naive BALB/c and C57BL/6 mice (Table 1), it ranged from
undetectable to low levels whatever the mice strain (Figure 3D left
and middle). Infection outcome 30 days p.i. did not modify
CXCL12 expression in BALB/c mice (Table 1), whereas C57BL/
6 mice displayed more CXCL12 in their mesothelium (Table 1,
Figure 3D right). In addition, slight hyperplasia of visceral pleural
mesothelium and nuclear pleomorphism were observed in infected
C57BL/6 mice (Figure 3D right). Once cultured, the pleural
mesothelial cells from infected-C57BL/6 mice released more
CXCL12 than the cells from infected BALB/c mice, whether they
were re-stimulated by L. sigmodontis crude extract or not (Figure 3E).
In addition, we checked that cultured mesothelial cells express
CXCR4 in both BALB/c and C57BL/6 mice (Figure 3F).
CXCL12/CXCR4 in Filarial Infection
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IL-5 pleural production
Treatment of infected C57BL/6 mice with either C04 or
AMD3100 had an impact on the intracellular levels of CXCL12 in
the pulmonary mesothelium, which shrunk to those observed in
naı ¨ve mice (Table 1). Accordingly, CXCL12 levels in the pleural
wash of infected C57BL/6 mice was also reduced by the two
treatments (Figure 4A). Because IL-5 has previously been shown to
be involved in the resolution of L. sigmodontis infection [37–39], the
presence of this cytokine was analyzed in the pleural wash.
Although IL-5 levels were significantly higher in C57BL/6 mice
than in BALB/c mice, the two treatments did not modify the
secretion of this cytokine (Figure 4B).
Disruption of CXCL12/CXCR4 axis delays worm
development in both strains of mice
L. sigmodontis larval stage 4 is expected to molt into the adult
stage around day 28 post inoculation in BALB/c mice; however, it
is also known that the timing of this molt is dependent on the
genetic background of the host [40]. Indeed, 17% of worms from
C57BL/6 mice were not yet adults 30 days p.i. whereas almost all
worms recovered from BALB/c mice were adults (98%) ([12] and
Figure 5A). The developmental stage is determined based on the
morphology of the buccal capsule, which appears as two thin lines
in stage 4, and consists of 3 identifiable segments in adults. At molt
4, larvae exhibit buccal capsules of both types (Figure 5B).
Surprisingly, in both strains of mice treated either by the chalcone
C04 or by AMD3100, the percentage of larval stage 4 and fourth
molting filariae increased 30 days p.i. (Figure 5A), from 17% to
35% and 30% in worms recovered from C57BL/6 mice and from
2% to 17% and 12% in worms recovered from BALB/c mice,
respectively treated with chalcone C04 or AMD3100. This
suggests that CXCL12 can be sensed by filariae as a cue for
development.
In order to understand the links between growth delay and the
treatment, a multiple factorial analysis was performed. The first
dimension constitutes an axis of resistance (29.92% of total
variance), from the susceptible BALB/c mice on the left with high
filariae counts (nF), to resistant C57BL/6 mice on the right
characterized by high levels of CXCL12 and IL-5 (Figure S4). To
discriminate the effect of the disruption of the CXCL12/CXCR4
axis (treatment), it was thus necessary to study axes 2 (20.25% of
total variance) and 3 (19.88% of total variance). CXCL12 levels
and the proportion of L4–M4 at 30 days p.i. are inversely
Figure 1. Filarial survival, pleural cell recruitment and CXCL12 levels during the course of the infection. A. Worms were collected
during the infection time course from 10 days p.i. to 60 daysp.i in C57BL/6 mice and 80 days p.i. in BALB/c mice and were counted (nF). B. Pleural
exudate cells (PleCs) were isolated at necropsy by flushing the pleural cavity and counted. C. The level of CXCL12 was measured during the course of
infection in pleural washes of C57BL/6 and BALB/c mice by ELISA (eBiosciences). Open squares represent BALB/c mice, black squares C57BL/6 mice.
Results are expressed as mean 6 SEM of 3 independent experiments pooled together, each carried out with 6 mice per group. The differences
between strains and the modifications during time course of the infection were analyzed by a two-way analysis of variance. For each analysis (nF,
PleCs, CXCL12), strain and time effects were significant. Comparison between strains for each time point was further assessed by Bonferroni’s multiple
comparison test. The character ‘‘*’’ represents significant differences between the C57BL/6 mice and the BALB/c mice (**p,0.005, ***p,0.001). D.
Correlation between the filarial load and number of the pleural exudate cells was assessed by Spearman’s test (r=20.576, p,0.01). E. Correlation
between the number of pleural exudate cells and the pleural CXCL12 concentration was assessed by Spearman test (r=0.674, p,0.01). Graphs show
the linear regression between the factors.
doi:10.1371/journal.pone.0034971.g001
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degree, IL-5 is also inversely correlated to the proportion of L4–
M4. Altogether, these results suggest a role of CXCL12, and to a
lesser extent of IL-5, in the development of filariae.
Low concentrations of CXCL12, but not high ones,
improve in vitro worm growth
L4-stage larvae (of length 3.8 mm60.07) were cultured for five
days either with CXCL12 (1 or 10 nM), AMD3100 (25 mg/ml),
Chalcone C04 (1 or 10 mM) or IL-5 (5 ng/ml). The medium used
for culturing the worms was tested by ELISA for the presence of
CXCL12 and was shown to be negative. The length of untreated
worms had increased by 1.2 mm at the end of the culture
(Figure 6). Low concentrations of CXCL12 significantly improved
the growth, increasing it to 2.12 mm, whereas high concentrations
did not, underlining a different effect of CXCL12 on filarial
growth according to its concentration (Figure 6). Chalcone C04,
AMD3100 and recombinant IL-5 had no impact on worm growth
(Figure 6). All filariae from these experiments presented rapid and
regular movements, and were thus neither dead nor moribund.
Discussion
This study highlights a key role of CXCL12 in the control of
filarial infection. Indeed, CXCL12 proved to be a host cell factor
which is critical for a fast clearance of the parasite in C57BL/6
mice (Figure S5A). In addition, a dual role for the CXCL12/
CXCR4 axis is suggested, as it modulates the growth of the
parasite in a mouse strain-independent manner, and thus is more
likely to have a direct effect on the parasite (Figure S5B).
Several studies have shown that the CXCL12/CXCR4 axis is
involved in the progression of diseases and infections. In murine
models of asthma, disruption of this axis has been shown to
decrease lung damage and airway reactivity, as illustrated by
reduction of airway resistance, decreased microvessel density and
general alteration in the development of airway inflammation
[36,41,42]. In murine models of malaria, the supplementation of
lethal infection models with CXCL12 induces a clear reduction in
Figure 2. Reversal of resistance upon CXCL12/CXCR4 axis
disruption. A. Filarial load 30 days post-inoculation in BALB/c mice (Bc,
light gray) compared to C57BL/6 mice (B6, dark grey) after the
disruption of the CXCL12/CXCR4 axis. Mice were treated with 100 mg
AMD3100 (AMD) or 2.5 mg chalcone C04 (C04) at 10 and 20 days post-
inoculation as described in Material and Methods. Results are expressed
as a barplot of 3 pooled independent experiments each carried out with
6 mice per group. The differences between strains and those between
treatments were analyzed by a two-way analysis of variance. Strain and
time effects were significant. Further comparisons were assessed by
Bonferroni’s multiple comparison test. The character ‘‘*’’ represents
significant differences between treatments within one strain of mice
(*p,0.05, **p,0.005, ***p,0.001); ‘‘#’’ shows significant differences
between strains for one given treatment (##p,0.005, ###p,0.001).
B. Pleural exudates cell (PleC) count. PleCs were counted at necropsy 30
days post-inoculation in BALB/c mice (Bc, light grey) and in C57BL/6
mice (B6, dark grey) after the disruption of the CXCL12/CXCR4 axis by
AMD3100 (AMD) or chalcone C04 (C04). Results are expressed as a
barplot of 3 pooled independent experiments, each carried with 6 mice
per group. The differences between strains and those between
treatments were analyzed by a two-way analysis of variance. Strain
and time effects were significant. Further comparisons were assessed by
Bonferroni’s multiple comparison test. The character ‘‘*’’ represents
significant differences between treatments within one strain of mice
(**p,0.005); ‘‘#’’ shows significant differences between strains for one
given treatment (##p,0.005). C. Pleural exudates cell composition.
PleCs were characterized by FACS analysis. Cells were labelled with
various antibodies and then analysed by flow cytometry (FACSCanto
BD, FACS DIVA version 6.0) as described in Material and Methods and
Figure S2. B cells are defined as cells expressing CD19, T cells as
expressing CD3, macrophages as expressing F4/80, eosinophils as
expressing Siglec F and neutrophils as expressing Ly6G. Although L.
sigmodontis infection does not mobilize neutrophils in the pleural cavity
at 30 days p.i., these granulocytes were analyzed to determine if
treatments can induce their recruitment. Due to their very low numbers
in all groups, neutrophils were not represented on the graph. Results
are expressed as the mean of 6 observations for each cell type and
represented as a stacked barplot. A multiple analysis of variance
(MANOVA) was used to determine if the proportion of each pleural
exudate cell type is modified between murine strains or by the
treatments: the proportion of the different PleC types was not modified
by the treatments, neither in Bc nor in B6 mice.
doi:10.1371/journal.pone.0034971.g002
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34971Figure 3. CXCL12 is produced by the mesothelium of C57BL/6 mice. A. Pleural exudate cells (PleCs) were harvested 30 days post-filarial
inoculation (p.i.), by PBS washing. The cells were stimulated for 72 hours with crude extract of adult (Ad) L. sigmodontis (10 mg/ml) or with 1 mg/ml of
the mitogen Concanavalin A (Con A). Levels of CXCL12 were detected by ELISA (eBiosciences) in the culture supernatant. Results are expressed as
mean 6 SEM, 6 mice per group. B. Differential levels of CXCL12 at 30 days p.i. in the sera of BALB/c mice (Bc) and C57BL/6 mice (B6) measured by
ELISA. Results are expressed as mean 6 SEM, 6 mice per group; unpaired t-test, non significant (NS). C. Chromogenic immunohistochemical staining
with cytokeratine 7 of paraffine-embedded visceral pleural mesothelium sections representative of naive or infected BALB/c and naive C57BL/6
tissues. Scale: bars=20 mm. D. Chromogenic immunohistochemical staining of paraffine-embedded tissue section of C57BL/6 and BALB/c visceral
pleural mesothelium: figures are representative of established scores as described in Material and Methods and in Table 1. From left to right: negative
(neg.) CXCL12 staining, weak CXCL12 staining (int. for intermediate), high CXCL12 staining (high). Same results were observed with the two
antibodies tested (polyclonal antibody, 1:500, eBioscience; biotinylated clone K15C, 1:200). Scale: bars=20, 10, 40 mm. E. Differential levels of CXCL12
in mesothelial cell supernatants was measured by ELISA. Mesothelial pleural cells were harvested by trypsine digestion from 12 BALB/c mice and 12
C57BL/6 mice 30 days post-filarial inoculation. Once at 70% of confluence, half of the cells were stimulated for 48 hours with crude extract of adult L.
sigmodontis (10 mg/ml, groups Bc Ad and B6 Ad). Unstimulated cells were also tested (Bc un and B6 un). Detail of culture conditions is provided in
Material and Methods. Results are presented after subtraction of the baseline production as a barplot showing medians and range. The differences
between strains were analysed by a Kruskall-Wallis test followed by a Dunn’s multiple comparison test. ‘‘*’’ represents significant differences between
the C57BL/6 mice and the BALB/c mice. F. Fluorescent immunological staining of CXCR4 on mesothelial cells culture. Scale: bars=15 mm.
doi:10.1371/journal.pone.0034971.g003
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tion of a CXCR4 receptor blocker causes an increase in circulating
parasites in the usually benign non-lethal P. chabaudi malaria in
C57BL/6 mice [43]. Similarly, in the L. sigmodontis model, blocking
the action of CXCL12 by either administrating the C04 chalcone
or a CXCR4 antagonist induces an increase in the filarial load in
resistant CXCL12-responsive C57BL/6 mice (Figure 2A, Figure
S5A). Thus, modification of the CXCL12/CXCR4 axis grants
control over the pathology’s development in these infection
models. The importance of CXCL12/CXCR4 axis in filarial
pathology is further supported by the fact that chronically infected
(lymphatic filariasis) but nevertheless asymptomatic individuals
have a lower expression of CXCR4 on T cells as compared to both
uninfected and resistant individuals [44].
The L. sigmodontis filarial infection is a Th2-based helminthiasis
[6] and the CXCL12/CXCR4 axis has been reported to have a
role in numerous Th2-based inflammatory diseases [32,42]. In
particular, disruption of the axis causes a decrease in cell
recruitment, as seen in asthma [41,42] or antigen-elicited
schistosomal granuloma formation (AESGF) [45]. Similarly, a
reduction of pleural cell recruitment was demonstrated herein in L.
sigmodontis filarial infection in treated resistant mice (Figure 2B).
Eosinophils are key players of a protective response against the
infective and adult stages of L. sigmodontis [37–39]. However, the
eosinophil population was not preponderantly impacted by the
blockade of the CXCL12/CXCR4 axis (Figure 2C), unlike in
asthma and AESGF [36,42,45]. Nevertheless, as with AESGF
[45], no clear deficit in Th2 cytokines was observed in the pleural
compartment, as indicated by unmodified IL-5 levels (Figure 4).
This difference may be related to the type of diseases studied, since
asthma and AESGF are inflammatory responses mainly caused by
eosinophils [36,42]. Furthermore, the kinetics of cell recruitment
studied in these diseases are short, up to 24 hours post-challenge
[36,42]. Besides eosinophils, the various cell types recovered in the
pleural cavity after disruption of the CXCL12/CXCR4 axis were
all reduced in the same proportion (Figure 2C and Figure S2).
Several species of filarioids establish themselves in lymphatics or
in coelomic cavities, which are bordered by endothelial or
mesothelial cells. These cells share numerous properties like the
capacity to produce a broad spectrum of chemokines and
chemokine receptors under inflammatory conditions, such as
CXCL8, CCL3, CXL12 for the mesothelial cells [28,46], CXCL1,
CXCL10, CXCL14 for endothelial cells, and CCL2 or CCL5 for
both types [47,48]. Mesothelial cells are distributed in a monolayer
that lines the pleural cavity. It allows dilatation/contraction of the
lung during breathing, regulates pleural permeability and provides
protection against pathogens [46]. For example, secretion of
chemokines by mesothelial cells has been shown to promote
leukocyte influx from the vascular compartment to the pleural
cavity via transmesothelial migration after infections such as
tuberculosis or bacterial peritonitis [49,50]. L. sigmodontis migrates
from the skin through the lymphatic system to the pleural cavity
where it matures and induces inflammation. Inflammatory
response is selectively stimulated, in respect to the strain of mice.
Indeed, the faster clearance of filarial infection appears in C57BL/
6 mice, within which a strong increase of chemokine concentra-
tions, including CXCL12, is measured in the pleural cavity,
peaking at the time of the 4th molt, i.e. around one month post
infection. Inflammatory chemokines such as CCL11 have been
detected in pleural fluid [12] and can be produced by pleural
exudate cells (Figure S1), whereas CXCL12 is produced by
mesothelial cells when infected by L. sigmondontis (Figure 3). In
contrast, the clearance of L. sigmodontis is comparatively slow in
susceptible BALB/c mice, which display a moderate increase of
chemokines throughout the infection (Figure 1, Figure S1). One
could thus hypothesize that increasing pleural CXCL12 levels in
susceptible BALB/c might confer them increased resistance
against the filaria. However, this approach is technically
compromised by the short half-life of recombinant CXCL12.
We don’t know yet the underlying mechanisms explaining the lack
of CXCL12/CXCR4-mediated immune response in BALB/c
mice, but for example the absence of a functional copy of Cxcl11
in C57BL/6 mice, contrary to BALB/c mice could be an
explanation. Indeed, as this chemokine signals through CXCR7,
the second receptor of CXCL12 [51], this difference may affect
the state of activation of the CXCL12/CXCR4 axis. The
importance of the CXCL12/CXCR4 axis in the susceptibility/
resistance phenotype against filariasis is further supported by the
recent observation of a correlation between high CXCR4
expression in PleCs and a low filarial recovery rate in granzyme-
deficient C57BL/6 mice presenting different degrees of suscepti-
bility after infection by L. sigmodontis [52].
This work is the first to highlight that mesothelial cells can act as
an important source of chemokines during filarial infection, and
suggests that the clearance of filariae is dependent on the capacity
of these cells to respond to the filariae. Mesothelial cells can
Table 1. CXCL12 intensity score in mesothelial cells.
Number of sections of lobes
Mice Total Neg. (score 0) Int. (score 5) High (score 10) Mean score/lobe
naive BALB/c 10 5 5 0 3
naive C57BL/6 11 9 2 0 1
inf. BALB/c 17 10 7 0 2
inf. C57BL/6 15 0 7 8 8
inf. C57BL/6 C04 8 6 2 0 1
inf. C57BL/6 AMD 8 3 5 0 3
The visceral pleural mesothelium from infected (inf.) and naive C57BL/6 and BALB/c mice was stained for CXCL12 (polyclonal antibody, 1:500, eBioscience; and
biotinylated monoclonal 1:200, clone K15C). Four animals were studied for each condition (6 groups: naive BALB/c, naive C57BL/6, infected BALB/c, infected C57BL/6,
infected and C04 or AMD3100-treated BALB/c and C57BL/6). 8 to 17 whole sections of pulmonary lobes were analyzed by light microscopy and discriminated according
to the intensity of CXCL12 staining in 3 categories: no detectable staining (Neg.), intermediate (Int.) or high intensity (High). The level of CXCL12 was arbitrarily scored as
0 (no detectable staining), 5 (intermediate staining), and 10 (high staining). A mean score (weighted mean) per section of pulmonary lobe was calculated according to
the coefficient defined previously.
doi:10.1371/journal.pone.0034971.t001
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(TLR) such as TLR2/1 and TLR2/6 [53,54]. The endobacteria
Wolbachia is able to signal through TLR2 and TLR6 [55] opening
the possibility that it contributes to the mesothelial responses.
Further work is needed to assess whether damaged filariae, and the
consequent exposure of Wolbachia, participates in the mechanism
that controls host-dependent chemokine production during the
course of the infection.
In addition to its role in filarial clearance, the CXCL12/
CXCR4 axis impacts the growth of the parasite independently of
the mouse strain, likely through a direct effect on the filariae
(Figure S5B). Filarioids can increase in size between molts [56].
However, the end of the molting process can be more or less
precocious depending on the host background. For example, L.
sigmodontis 4
th molt happens faster in rodents in which filarial
infection is cleared slowly [40,57]. Conversely, in resistant
C57BL/6 mice, a molting delay has been reported in previous
studies [12] and in the current one (Figure 5A).
The use of the L. sigmodontis murine infection model suggests
that immune parameters can be environmental factors influencing
the development and the fitness of the parasite. IL-5 has been
shown to control the growth of L. sigmodontis only in presence of
eosinophils [58]. IL-4 and IL-5 are also important in the
regulation of worm fertility, because infected IL-4 KO and IL-5
KO mice produce more microfilariae, and for a longer period of
time [59]. In the current study, CXCL12 was shown to be able to
modify the growth in a non-linear dose-dependent manner within
a controlled in vitro environment (Figure 6). Indeed, as in vivo,a
high concentration of CXCL12 (i.e. in C57BL/6 mice) limited the
growth of the parasite, while a low concentration of CXCL12 (i.e.
in BALB/c mice) favored it. Furthermore, neither C04 chalcone
nor AMD3100 had a direct effect in vitro when incubated with
filariae in the absence of CXCL12. This suggests that filariae
possess a CXCR4-like receptor able to sense pleural CXCL12
(Figure S5B). At high concentrations of this chemokine the
consequences on filarial growth are negative, most probably as a
result of receptor desensitization. The waning of responses from
cell surface activated receptors during persistent stimulation with
agonists (e.g. desensitization) is a feature shared by many G protein
coupled receptors, including the chemokine receptor family. For
instance, impaired desensitization of CXCR4 leads to abnormally
enhanced responses to CXCL12 [60–62]. Thus, under our
hypothesis, preventing the signalling of CXCL12 on its receptor
by using AMD3100 or the chalcone C04 would also impair worm
development, whatever the mouse strain, as is indeed observed.
The presence of an ortholog/mimic of CXCR4 in the filarial
genome was assessed on Brugia malayi genome, as the genome of
Litomosoides sigmodontis is not yet available. However, genome-wide
BLAST searches conducted on the Nembase sequence databases
(www.nematodes.org/nembase4/) failed to yield a significant
match for human or murine CXCR4 sequences (data not shown).
Nevertheless, CXCR4 is the most conserved chemokine
receptor among vertebrates and is even known to be present
in ancestral fish families, such as the chondrostian and
elasmobranch taxa, which diverge early in vertebrate evolution
[63,64]. Invertebrates are generally considered to be free of G-
protein-coupled receptors (GPCRs) of the rhodopsin c family,
which includes chemokine receptors [65]. However, the urochor-
date sea squirt Ciona intestinalis, one of the closest invertebrate
relatives to vertebrates, has been reported to have GPCRs from
this family [66], thus stressing the possibility that invertebrates
might possess chemokine-like pathways. Furthermore, even if
orthologs/mimics of mammalian chemokine receptors have not
been identified in Nematodes yet, chemokine-like proteins and
receptors of Nematodes are known to be able to interfere with
mammalian chemokine pathways, raising the possibility that
filarioidea possess a CXCR4 mimic able to interact with
mammalian system.
In conclusion, this study demonstrated that the abrogation of the
CXCL12/CXCR4 axis in L. sigmodontis infection of fast-clearing
mice reverses the resistant phenotype, with lower pleural cell
recruitment and higher worm survival rate. Conversely, this
increased survival is compromised by an alteration of worm
development, independently of the host’s genetic background.
As the differences of susceptibility in the L. sigmodontis mouse
modelcanreflectthelargepanelofclinical manifestations[6–9],the
study of CXCL12-dependant mechanisms of filarial destruction in
resistant mice might yield interesting new therapeutic targets.
Figure 4. Pleural levels of CXCL12 and IL-5 after disruption of the CXCL12/CXCR4 axis. CXCL12 (A) and IL-5 (B) expression levels measured
by ELISA in pleural fluid of BALB/c mice and C57BL/6 mice 30 days post-inoculation and upon blockade either by chalcone (C04) or by AMD3100
(AMD) (days 10 and 20 p.i.). Results are presented after subtraction of the baseline production as mean 6 SEM of 3 pooled independent experiments
each carried out with 6 mice per group. The differences between strains and treatments were analysed by a two-way analysis of variance. Strain and
treatment effects were significant for the pleural CXCL12 levels, and only the strain effect was significant for the pleural IL-5 level. Further
comparisons were assessed by Bonferroni’s multiple comparison test. ‘‘*’’ represents significant differences between treatments within one strain of
mice (*p,0.05, **p,0.01); # shows significant differences between strains for one given treatment (###p,0.001).
doi:10.1371/journal.pone.0034971.g004
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Ethics Statement
All experimental procedures werecarried out in strict accordance
with the 2003/65/CEE European directive for animal experimen-
tation. National license number 75–1415 approved animal
experiments. Protocols were approved by the ethical committee of
the ‘‘Museum National d’Histoire Naturelle’’ (MNHN) and by the
‘‘Direction de ´partementale de la cohe ´sion sociale et de la protection
des populations’’ (DDCSPP) (nu75-05-15).
Parasites, mice, infection, treatments
Litomosoides sigmodontis was maintained in our laboratory, and
infective third-stage larvae (L3) were recovered by dissection of the
mite vector Ornithonyssus bacoti as previously described [38,67].
Crude extract of L. sigmodontis worms were obtained by
homogenization and sonication of adults recovered from jirds
(sex ratio 1:1) as previously described [12]. After centrifugation,
the supernatant was collected and frozen at 280uC until further
use. Protein content was determined by the modified Bradford
method (BCA
TM Protein Assay kit, Pierce).
Six-week-old female C57BL/6 and BALB/c mice were
purchased from Harlan (France) and maintained in the MNHN
animal facilities. Forty infective L3 in 200 ml of RPMI 1640 were
inoculated subcutaneously into the left lumbar area of mice.
Kinetics of infection were followed over 80 days of infection. Mice
were sacrificed at 10, 30, 60, and 80 days post-inoculation (p.i.).
Groups of mice were twice treated intraperitoneally with 2.5 mg
of chalcone C04 dissolved in 1% Carboxy Methyl Cellulose
(Sigma) 10 and 20 days p.i. according to the protocol described by
Hachet-Haas et al. [36] or with 100 mg of AMD3100 in 0.9%
NaCl (Sigma) using the same schedule. Mice were sacrificed 30
days p.i.
At least six mice were used for each group, and each experiment
was repeated 3 times.
Filarial load, pleural leukocyte recovery, flow cytometry
The mice were anesthetized and sacrificed by final bleeding.
The pleural cavity was washed with 10 ml of cold phosphate
Figure 5. The CXCL12/CXCR4 axis affects filarial development.
A. Percentage of adults (dark grey) and non adults (light grey), i.e. stage
4 (L4) or molt 4 (M4), recovered 30 days post-inoculation after
treatment with chalcone (C04) or AMD3100 (AMD). Results are
presented in stacked column chart; binomial glm (see Materials and
method for details). B. Morphology of L. sigmodontis buccal capsule of
fourth stage (L4), during fourth molting (M4), and of adult (Ad) by light
microscopy. The fourth stage has a thin buccal capsule, composed of
two thin walls (dark arrow), the fourth molt simultaneously presents the
buccal capsule of the fourth stage (dark arrow) and the buccal capsule
characteristic of the adult stage with three large segments. Scale:
bars=20 mm. C. Multiple factorial analysis (MFA) of the parameters
implicated in the study: pleural CXCL12, pleural IL-5, number of pleural
exudate cells (PleCs), number of filariae (nF), and the percentage of
stage 4 and molt 4 (L4–M4). For a non-biased representation of the data
observed either on mice or on filariae, PleCs, IL-5, and CXCL12 factors
were grouped together on one hand, and the number of filariae and
L4–M4 factors on the other hand. Controlled variables, such as strain or
treatment, were considered as illustrative.
doi:10.1371/journal.pone.0034971.g005
Figure 6. CXCL12 has direct effect on worm growth in vitro.
Length of filariae (mm) was measured before and after 5 days of in vitro
culture. Groups of filariae were constituted and treated with either
CXCL12 (1 nM, 10 nM), Chalcone C04 (C04, 1 mM, 10 mM), AMD3100
(AMD, 25, 50 mg/ml) or IL-5 (5 ng/ml). Treatments were added daily to
wells containing two filariae in 1 ml, as detailed in Materials and
Method. Length increase was expressed as median 6 interquartile
range of 30 filariae for control group (Ctrl, medium only), 20 for other
groups, and 10 for the IL-5 treated group. The differences between
treatments were analysed by a non parametric Kruskall-wallis test
followed by Dunn’s multiple comparison test, with control group as
reference. ‘‘*’’ marks significant differences between treated filariae and
the control group (*p,0.05).
doi:10.1371/journal.pone.0034971.g006
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infiltrating cells as well as the worms were collected from the
pleural wash for further analysis.
The following parasite features were analyzed by light
microscopy on materials fixed in toto with 4% formaldehyde in
cold PBS to avoid body shrinkage: i) L4/molt 4/adults; ii) gender.
Pleural exudates cells (PleCs) were centrifuged at 250 g for 8 min
at 4uC, resuspended in 1 ml RPMI supplemented with 10% foetal
calf serum (FCS) and counted in PBS20.04% trypan blue (Sigma-
Aldrich) by using a haematocyter. Proportions of the different
leukocyte populations were determined by flow cytometry.
The following rat anti-mouse antibodies were used for analysis
of cell composition in the pleural cavity: anti-CD19-APC (dilution
1:25, BD Pharmingen, clone 1D3) as a marker of B cells; anti-
CD5-PE (dilution 1:25, BD Pharmingen, clone 53-7.3), a marker
found on B1 cells and not on B2 cells; anti-CD3-PEcy5 (dilution
1:25, BD Pharmingen, clone 17A2) as a marker of T cells; anti-
F4/80-APC (dilution 1:50; eBioscience, clone BM8), a marker of
macrophages, SiglecF-PE (dilution 1:40, BD Bioscience, clone
E50-2440) as a marker of eosinophils, and Ly6G-PE-Cy7
(eBioscience, clone RB6-8C51:40) as a marker of neutrophils.
Controls were made with the appropriate isotype control.
Acquisition and analyses were performed as described in Figure
S1. Flow cytometry analysis was performed using a FACSCanto
flow cytometer running the FACS DIVA software (BD Bioscienc-
es).
PleCs culture and ELISA of culture supernatants, pleural
wash fluids, and sera
PleCs were cultured in duplicate in 96-well plates, with 2.5610
5
cells/well in RPMI 1640 medium supplemented with 10% FCS,
2 mM L-glutamine (Sigma Aldrich), 100 U of penicillin per ml,
and 100 mg of streptomycin per ml (Eurobio), and stimulated for
72 hours (h) with Ad filarial extract (10 mg/ml) or ConA (1 mg/ml)
at 37uC in 5% CO2-enriched atmosphere.
Pleural wash fluids (dilution 1:3), sera (dilution 1:5) or culture
cells supernatant (dilution 1:3) collected from individual mice were
assayed for cytokine content by enzyme-linked immunosorbent
assay (ELISA) in duplicate. These assays were performed
according to the manufacturer’s recommendations, using
CXCL12 ELISA kits (e-Bioscience or R&D) and IL-5 ELISA kit
(e-Bioscience). Results are expressed as picograms by milliliter.
Detection limits were 44 pg/ml for CXCL12 and 4 pg/ml for IL-
5.
Isolation, characterization of murine pleural mesothelial
cells, CXCL12 titration and CXCR4 immunostaining
Mesothelial cells were obtained by a 20 minute trypsin digestion
of visceral and parietal pleural mesothelium. Mice were injected
with 1.2 mL of trypsin-EDTA 0.25% in the pleural cavity at 37uC.
The external face of the pleural cavity was kept moist with PBS
and massaged periodically to improve cell detachment. The cavity
was then gently washed with 10 ml of RPMI supplemented with
10% of FCS to neutralize the trypsin.
The media containing the cells were centrifuged at 200 g for
5 minutes. The cells were washed three times in RPMI 1640
supplemented with 20% FCS, 2 mM L-glutamine, 100 U of
penicillin per ml, 100 g of streptomycin per ml, gentamicine
250 mg/ml, 20 mM HEPES and then cultured in T25 flasks for 6–
8 days at 37uC in a 5% CO2-enriched atmosphere until they were
subconfluent. Mesothelial cells were characterized according to
their shape and following cytokeratin 7 staining (1:50, clone AE1/
AE3, DAKO). Cells from 30 days p.i. infected-BALB/c and-
C57BL/6 mice were seeded at 1 million cells per mL in 24-well
plates and then stimulated or not with filarial extract (10 mg/ml).
Supernatants were recovered after 48 hours of culture for
CXCL12 titration by ELISA as described above.
After the first passage, mesothelial cells were grown on chamber
slides for 2 days (Lab-Teck, Polylabo, France). Cells were treated
with Brefeldin A (10 mg/ml) for the last 4 h of culture. Cells were
washed and fixed with 4% paraformaldehyde in PBS for 10 min at
4uC, permeabilized with PBS 0.2% BSA, 0.05% Saponine buffer
for 30 min at 4uC, incubated with the anti-CXCR4 polyclonal
antibody (Thermo Scientific, France) for 30 min at 4uC, and
finally incubated with secondary Ab goat anti-rabbit IgG-Alexa
Fluor 488 (Molecular Probes). After 3 washes in PBS, slides were
mounted with Fluoromount-G (Southern Biotechnology Associ-
ates). Images were taken using an inverted microscope Zeiss
Axiovert 200 M piloted by the Zeiss Axiovision 4.4 software,
acquired with a CCD camera Roper Scientific Coolsnap HQ, and
analysed using the AxioVision LE program.
Immunohistology of visceral pleural mesothelium
To expand the lungs of BALB/c and C57BL/6 mice and to
preserve the structure of the visceral pleural mesothelium, they
were injected through the trachea with 4% formaldehyde in cold
PBS. The organs were then fixed for 48 h by immersion in 4%
formaldehyde. Fixed samples were embedded in paraffin and 5-
mm-thick sections were prepared. The tissues were deparaffinized
with toluene and then hydrated using a series of decreasing
concentrations of ethanol. The visceral pleural mesothelium was
stained for cytokeratin 7, a marker of mesothelial cells (1:50, clone
AE1/AE3, DAKO) or CXCL12 (polyclonal antibody, 1:500,
eBioscience; and biotinylated monoclonal 1:200, clone K15C,
[69]). Binding of these antibodies was detected by HRP or HRP-
linked universal secondary antibody (DAKO) and AEC substrate
(DAKO). The sections were counterstained with a Mayer
Hematoxylin solution. Four animals were studied for each
condition and stained lung sections were examined by light
microscopy. The level of CXCL12 was arbitrary scored as 0 (no
detectable staining), 5 (intermediate staining), and 10 (high
staining). Representative images were chosen for each staining
intensity (negative, intermediate or high). The numerical scoring
was confirmed by a second independent examination, blinded to
the initial score.
In vitro culture of larvae
L4-stage larvae were recovered 15 days after L3 inoculation by
flushing the pleural cavity of jirds with cold PBS. The larvae were
then washed twice by a medium constituted of RPMI 1640, 25%
SVF, 2 mM L-glutamine (Sigma Aldrich), 100 U of penicillin per
ml, 100 mg of streptomycin per ml (Eurobio), HEPES 20 mM,
glucose 1.1%, vitamin C 75 mM, and BSA 3%.
L4 were seeded two per well in 24 well culture plates and the
medium was changed each day from day 0 to day 5. Filariae were
stimulated from day 1, with CXCL12 (1 or 10 nM), AMD3100
(25 mg/ml or 50 mg/ml), Chalcone C04 (1, 10 mM) or IL-5 (5 ng/
ml). The general appearance of cultured worms was observed each
day. Pictures were taken regularly for length measurement after
immobilization of the worms by 30 minutes at 4uC.
Statistics
The choice of statistical tests was based on sample size and on
Bartlett’s test when normal distributions of the errors were
expected. Data from separate experiments were pooled when
possible. Results were analyzed with two-way ANOVA in order to
determine the effects of 2 factors, i.e. the strain and the treatment.
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treated groups to untreated groups in each mouse strain, or to
compare the two strains similarly treated. For in vitro experiments,
non-parametric Kruskall-Wallis’s H-test was used. Pleural exu-
dates cell composition was analyzed by MANOVA. Binomial
generalized linear models (glm) were used to assess the effects of
treatment and strain on growth delay. Multiple factorial analysis
(MFA) was performed to represent the links between the variables
involved in this study. Representation and data analysis were
performed with R [70] or the GraphPad Prism 5 software.
Statistically significant values are indicated as follows: *: p,0.05;
**: p,0.01; and ***: p,0.001.
Accession Numbers
The GenBank accession numbers used to search for the
CXCR4 ortholog in Brugia malayi are HGNC:2561 for the human
CXCR4 gene and MGI:109563for the murine CXCR4 gene.
Supporting Information
Figure S1 Differential kinetics of pleural chemokine
levels between C57BL/6 and BALB/c mice. Differential
CCL2 (A) , CCL3 (B) and CCL11 (C) response between BALB/c
mice (Bc) and C57BL/6 mice (B6) in pleural fluid during the
course of infection. Pleural wash fluids (dilution 1:3) were assayed
for cytokine content by enzyme-linked immunosorbent assay
(ELISA) in duplicate. These assays were performed according to
the manufacturer’s recommendations, using CCL2, CCL3 and
CCL11 ELISA kits (Peprotech). Results are given in picograms per
milliliter. Results are expressed as mean 6 SEM of 3 pooled
independent experiments each carried out with 6 mice per group.
Two ways analysis of variance followed by Bonferroni multiple
comparison test. *: p,0.05, **: p,0.005, ***: p,0.001.
(TIF)
Figure S2 Cytometry analysis of pleural exudate cells.
A. Pleural exudate cells were characterized by FACS analysis.
Cells were labelled with various antibodies and then analysed by
flow cytometry (FACSCanto BD, FACS DIVA version 6.0). From
left to right : gating of macrophages and eosinophils is defined on a
F4/80/Siglec F plot: gate for macrophages is defined as high and
intermediate expression of F4/80 combined to low to intermediate
expression of Siglec F; gate for eosinophils is defined as high
expression of Siglec F; gating of neutrophils is defined on high
expression of Ly6G; gating of B and T cells is defined on a CD19/
CD5 expression plot; gate for B cells is in the left top corner; gate
for T cells is in the right bottom corner. B. Results presented are
the mean 6 SEM of 6 observations. MANOVA, significative
effect of strain (on total number of PleCs), no effect of treatment.
(TIF)
Figure S3 Differential production of chemokines by
PleCS between C57BL/6 and BALB/c mice. Differential
CCL2 (A) , CCL3 (B) and CCL11 (C) responses between BALB/c
mice (Bc) and C57BL/6 mice (B6) in PleC surpernatant. Pleural
exudate cells (PleCs) were harvested by PBS washing 30 days post-
filarial inoculation (F) or from naive mice (N). The cells were
stimulated for 72 hours by a crude extract of adult (Ad) L.
sigmodontis (10 mg/ml) or with 1 mg/ml of the mitogen Concanav-
alin A (C), or were left unstimulated (us). Levels of CCL2, CCL3,
CCL11 were detected by ELISA (Peprotech) in the culture
supernatant. Results are expressed as picograms by milliliter.
Results are expressed as mean 6 SEM of 3 pooled independent
experiments each carried out with 6 mice per group. Two-way
analysis of variance followed by Bonferroni multiple comparison
test. *p,0.05, **p,0.005, ***p,0.001.
(TIF)
Figure S4 Multiple factorial analysis of worm and
immune parameters: focus on the first dimension. A.
Individuals plot in factorial plane (1, 2) shows a marked separation
between the two strains. B. Correlation circle of the axis 1 and 2
presenting the patterns of responses in resistant versus susceptible
mice: low number of filariae (nF), high recruitment of pleural
exudates cells (PleCs), high CXCL12 and IL-5 concentration
(CXCL12.LP, IL5.LP), high number of stage 4 larvae and fourth
molting filariae (L4–M4).
(TIF)
Figure S5 Schematic overview of the regulation of
filarial survival and development by the CXCL12/
CXCR4 axis in the pleural cavity. A. The CXCL12/
CXCR4 axis controls filarial survival in C57BL/6 non permissive
mice. Survival of L. sigmodontis is represented in the pleural cavity
of C57BL/6 and BALB/C mice, before and after treatments
disrupting the CXCL12/CXCR4 axis. Without treatments
(control), C57BL/6 mice pleural mesothelial cells produce high
levels of CXCL12 that correlate with low levels of filariae and high
numbers of pleural exudate cells. On the contrary, BALB/c mice
pleural mesothelial cells produce low levels of CXCL12 that
correlate with high levels of filariae and low numbers of pleural
exudate cells. After CXCR4 blockade by AMD3100 treatment,
mesothelial cells from C57BL/6 mice produce low levels of
CXCL12; these mice also have a lower number of pleural exudate
cells equivalent to the one of BALB/c mice and an intermediate
number of filariae between C57BL/6 and BALB/c mice. After
AMD3100 treatment in BALB/c mice, levels of CXCL12,
numbers of pleural exudate cells and of filariae are in all points
similar to untreated BALB/c mice. After chalcone C04 treatment,
C57BL/6 mice have a low level of CXCL12, a high number of
filariae and a low number of pleural exudate cells, all equivalent to
BALB/c mice. After chalcone C04 treatment in BALB/c mice,
levels of CXCL12, numbers of pleural exudate cells and of filariae
are in all points similar to untreated BALB/c mice. B. L. sigmodontis
development is dependant of the CXCL12/CXCR4 axis in both
C557BL/6 and BALB/c mice. A hypothetical explanation of the
effect of CXCL12 on the filarial development is presented. The
mechanism relies on the existence of a L. sigmodontis CXCR4-like
receptor (fCXCR4-like) and the capacity of chemokine receptors
to be desensitized in presence of high levels of ligand. In C57BL/6
mice, the pleural cavity is rich in CXCL12. This high level could
cause desensitization of the fCXCR4-like receptor, thus retarding
the growth of the parasite. Inversely, BALB/c mice present a low
level of CXCL12 in the pleural cavity that activates fCXCR4-like
receptor thus favoring growth. After AMD3100 treatment,
C57BL/6 and BALB/c mice present low level of CXCL12 in
the pleural cavity. However, according to our in vitro data,
AMD3100 could block a homolog/mimicry of CXCR4, thus
retarding the growth. After chalcone C04 treatment, the CXCL12
level is also low in the pleural cavity of both C57BL/6 and BALB/
c mice, but the interaction of the chalcone with CXCL12 could
prevent CXCL12/fCXCR4-like interaction, thus retarding the
growth of L. sigmodontis.
(TIF)
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